SCHEMBL8329971

SCHEMBL8329971

C1=N\N2CCCC2CCCC/1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1022055 0.91
SCHEMBL209980 0.89
SCHEMBL5641486 0.87
SCHEMBL9143007 0.85
SCHEMBL23346129 0.82
SCHEMBL12967506 0.77
SCHEMBL9546334 0.76
SCHEMBL9246749 0.74 ALDH1A1 (0.33)
SCHEMBL4943400 0.70
SCHEMBL843801 0.67 L3MBTL3 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6004956-A CHEMICAL INTERMEDIATES FOR BACTERICIDES BAYER AKTIENGESELLSCHAFT (DE) 1999-12-21 US disclosed
EP-0551653-B1 Enantiomeric pure cis-2-oxa-5,8-diazabicyclo (4.3.0)nonanes and process for their preparation BAYER AG (DE) 1999-03-17 EP disclosed
US-5532364-A FROM A DIHYDROPYRIDINE DERIVATIVE BAYER AKTIENGESELLSCHAFT (DE) 1996-07-02 US disclosed
US-5436334-A Enantiomerically pure 2-oxa-5,8-diazabicyclo[4.3.0]nonanes and process for their preparation BAYER AKTIENGESELLSCHAFT (DE) 1995-07-25 US disclosed
EP-0551653-A1 Enantiomeric pure 2-oxa-5,8-diazabicyclo (4.3.0)nonanes and process for their preparation BAYER AG (DE) 1993-07-21 EP disclosed